Disclosure 0001628280-26-058920-1

SEC FORM 4

$62,957.64

Allogene Therapeutics, Inc. (ALLO)

Sale of 29,697 shares at $2.12 per share.

Reporting Person Douglas Earl Martin · Officer Title SVP, General Counsel · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001628280-26-058920 · filed 2026-08-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Allogene Therapeutics, Inc. (ALLO)." Disclosed 2026-08-25. https://desqlong.com/cards/0001628280-26-058920-1 (retrieved 2026-09-26).